Mislabeling is a problem with medical marijuana!

A study published in the Journal of the American Medical Association says 75 edible medical cannabis products purchased (under 47 different brands) in Los Angeles, San Francisco, and Seattle, 17 percent were accurately labeled, 23 percent were under-labeled, and 60 percent were over-labeled with respect to tetrahydrocannabinol (THC) content. Over-labeled products were most common in Los Angeles; under-labeled products were common in Seattle. Non–THC content was generally low. Forty-four products (59 percent) had detectable levels of cannabidiol (CBD), but only 13 had labeled CBD content. Four products were over-labeled for CBD, and 9 were under-labeled. The median THC:CBD ratio of products with detectable CBD was 36:1; 7 had ratios of less than 10:1; and only 1 had a 1:1 ratio.
Read more:
http://jama.jamanetwork.com/article.aspx?articleid=2338239